These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16718707)

  • 1. Ibuprofen and the mouse model of Parkinson's disease.
    Kurkowska-Jastrzebska I; Członkowski A; Członkowska A
    Ann Neurol; 2006 Jun; 59(6):988-9. PubMed ID: 16718707
    [No Abstract]   [Full Text] [Related]  

  • 2. Ibuprofen, inflammation and Alzheimer disease.
    Wyss-Coray T; Mucke L
    Nat Med; 2000 Sep; 6(9):973-4. PubMed ID: 10973311
    [No Abstract]   [Full Text] [Related]  

  • 3. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
    van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
    Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
    Liu B; Dluzen DE
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
    Byrne ST; Denkin SM; Zhang Y
    J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis.
    Kadota T; Shingo T; Yasuhara T; Tajiri N; Kondo A; Morimoto T; Yuan WJ; Wang F; Baba T; Tokunaga K; Miyoshi Y; Date I
    Brain Res; 2009 Feb; 1254():120-7. PubMed ID: 19101524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiloride is neuroprotective in an MPTP model of Parkinson's disease.
    Arias RL; Sung ML; Vasylyev D; Zhang MY; Albinson K; Kubek K; Kagan N; Beyer C; Lin Q; Dwyer JM; Zaleska MM; Bowlby MR; Dunlop J; Monaghan M
    Neurobiol Dis; 2008 Sep; 31(3):334-41. PubMed ID: 18606547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
    Kim S; Moon M; Park S
    J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B; Verma R; Khanna P; Sharma SK
    Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A hormonal drug melatonin in the treatment of cognitive function disorders in parkinsonism].
    Arushanian EB
    Eksp Klin Farmakol; 2010 Mar; 73(3):35-9. PubMed ID: 20408429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX; Chen WF; Xie JX; Wong MS
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ibuprofen for Alzheimer's?].
    Holzgrabe U
    Pharm Unserer Zeit; 2002; 31(2):130. PubMed ID: 11977446
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in the treatment of Parkinson's disease.
    Singh N; Pillay V; Choonara YE
    Prog Neurobiol; 2007 Jan; 81(1):29-44. PubMed ID: 17258379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen.
    Nurs Times; 2005 Apr 12-18; 101(15):37. PubMed ID: 15850261
    [No Abstract]   [Full Text] [Related]  

  • 16. Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
    Morissette M; Al Sweidi S; Callier S; Di Paolo T
    Mol Cell Endocrinol; 2008 Aug; 290(1-2):60-9. PubMed ID: 18515001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSAIDs ameliorate cognitive and motor impairment in a model of parkinsonism induced by chlorpromazine.
    Naeem S; Ikram R; Khan SS; Rao SS
    Pak J Pharm Sci; 2017 May; 30(3):801-808. PubMed ID: 28653925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non! to non-steroidal anti-inflammatory therapy for inflammatory lung disease in cystic fibrosis (at least at the moment).
    Bush A; Davies J
    J Pediatr; 2007 Sep; 151(3):228-30. PubMed ID: 17719925
    [No Abstract]   [Full Text] [Related]  

  • 19. Ibuprofen: new indication. Migraine attacks: don't begin with 400 mg!
    Prescrire Int; 2007 Dec; 16(92):244. PubMed ID: 18092409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ibuprofen: a febrile rumor].
    Annequin D; Carbajal R
    Arch Pediatr; 2005 Feb; 12(2):125-7. PubMed ID: 15694533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.